These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 36743418)

  • 41. Is the ADP ribose site of the Chikungunya virus NSP3 Macro domain a target for antiviral approaches?
    Shimizu JF; Martins DOS; McPhillie MJ; Roberts GC; Zothner C; Merits A; Harris M; Jardim ACG
    Acta Trop; 2020 Jul; 207():105490. PubMed ID: 32333884
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Disruption of the Opal Stop Codon Attenuates Chikungunya Virus-Induced Arthritis and Pathology.
    Jones JE; Long KM; Whitmore AC; Sanders W; Thurlow LR; Brown JA; Morrison CR; Vincent H; Peck KM; Browning C; Moorman N; Lim JK; Heise MT
    mBio; 2017 Nov; 8(6):. PubMed ID: 29138302
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chikungunya virus requires cellular chloride channels for efficient genome replication.
    Müller M; Slivinski N; Todd EJAA; Khalid H; Li R; Karwatka M; Merits A; Mankouri J; Tuplin A
    PLoS Negl Trop Dis; 2019 Sep; 13(9):e0007703. PubMed ID: 31483794
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cryo-EM Structure of Chikungunya Virus in Complex with the Mxra8 Receptor.
    Basore K; Kim AS; Nelson CA; Zhang R; Smith BK; Uranga C; Vang L; Cheng M; Gross ML; Smith J; Diamond MS; Fremont DH
    Cell; 2019 Jun; 177(7):1725-1737.e16. PubMed ID: 31080061
    [TBL] [Abstract][Full Text] [Related]  

  • 45. pH-Dependent entry of chikungunya virus fusion into mosquito cells.
    Nuckols JT; McAuley AJ; Huang YJ; Horne KM; Higgs S; Davey RA; Vanlandingham DL
    Virol J; 2014 Dec; 11():215. PubMed ID: 25476236
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential Transmission of Antiviral Drug-Resistant Chikungunya Viruses by
    Delang L; Yen PS; Vallet T; Vazeille M; Vignuzzi M; Failloux AB
    mSphere; 2018 Aug; 3(4):. PubMed ID: 30135220
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preparation of vesicular stomatitis virus pseudotype with Chikungunya virus envelope protein.
    Tong W; Yin XX; Lee BJ; Li YG
    Acta Virol; 2015 Jun; 59(2):189-93. PubMed ID: 26104337
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chikungunya virus induces a more moderate cytopathic effect in mosquito cells than in mammalian cells.
    Li YG; Siripanyaphinyo U; Tumkosit U; Noranate N; A-nuegoonpipat A; Tao R; Kurosu T; Ikuta K; Takeda N; Anantapreecha S
    Intervirology; 2013; 56(1):6-12. PubMed ID: 22907160
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A polarized cell model for Chikungunya virus infection: entry and egress of virus occurs at the apical domain of polarized cells.
    Lim PJ; Chu JJ
    PLoS Negl Trop Dis; 2014 Feb; 8(2):e2661. PubMed ID: 24587455
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Host Factors and Pathways Involved in the Entry of Mosquito-Borne Alphaviruses.
    De Caluwé L; Ariën KK; Bartholomeeusen K
    Trends Microbiol; 2021 Jul; 29(7):634-647. PubMed ID: 33208275
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Suramin Inhibits Chikungunya Virus Entry and Transmission.
    Ho YJ; Wang YM; Lu JW; Wu TY; Lin LI; Kuo SC; Lin CC
    PLoS One; 2015; 10(7):e0133511. PubMed ID: 26208101
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structural basis of Chikungunya virus inhibition by monoclonal antibodies.
    Zhou QF; Fox JM; Earnest JT; Ng TS; Kim AS; Fibriansah G; Kostyuchenko VA; Shi J; Shu B; Diamond MS; Lok SM
    Proc Natl Acad Sci U S A; 2020 Nov; 117(44):27637-27645. PubMed ID: 33087569
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Chikungunya Virus
    Bartholomeeusen K; Utt A; Coppens S; Rausalu K; Vereecken K; Ariën KK; Merits A
    J Virol; 2018 Jul; 92(14):. PubMed ID: 29695432
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The CD147 Protein Complex Is Involved in Entry of Chikungunya Virus and Related Alphaviruses in Human Cells.
    De Caluwé L; Coppens S; Vereecken K; Daled S; Dhaenens M; Van Ostade X; Deforce D; Ariën KK; Bartholomeeusen K
    Front Microbiol; 2021; 12():615165. PubMed ID: 33717005
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CHIKV strains Brazil (wt) and Ross (lab-adapted) differ with regard to cell host range and antiviral sensitivity and show CPE in human glioblastoma cell lines U138 and U251.
    Hucke FIL; Bestehorn-Willmann M; Bassetto M; Brancale A; Zanetta P; Bugert JJ
    Virus Genes; 2022 Jun; 58(3):188-202. PubMed ID: 35347588
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mutation of the N-Terminal Region of Chikungunya Virus Capsid Protein: Implications for Vaccine Design.
    Taylor A; Liu X; Zaid A; Goh LY; Hobson-Peters J; Hall RA; Merits A; Mahalingam S
    mBio; 2017 Feb; 8(1):. PubMed ID: 28223458
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genome-Wide Approaches to Unravel the Host Factors Involved in Chikungunya Virus Replication.
    Tanaka A; Suzuki Y
    Front Microbiol; 2022; 13():866271. PubMed ID: 35401487
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antiviral activities of niclosamide and nitazoxanide against chikungunya virus entry and transmission.
    Wang YM; Lu JW; Lin CC; Chin YF; Wu TY; Lin LI; Lai ZZ; Kuo SC; Ho YJ
    Antiviral Res; 2016 Nov; 135():81-90. PubMed ID: 27742486
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evolution and immunopathology of chikungunya virus informs therapeutic development.
    Henderson Sousa F; Ghaisani Komarudin A; Findlay-Greene F; Bowolaksono A; Sasmono RT; Stevens C; Barlow PG
    Dis Model Mech; 2023 Apr; 16(4):. PubMed ID: 37014125
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recent progress on chikungunya virus research.
    An W; Ge N; Cao Y; Sun J; Jin X
    Virol Sin; 2017 Dec; 32(6):441-453. PubMed ID: 29188427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.